Track historical performance and analyze price trends
.avif&w=3840&q=75)
Last updated: 14 June 2025
1M Change
-1.04%
6M Change
-12.84%
1Y Change
-9.52%
Recent decline may present a potential entry opportunity for long-term investors.
The mid-term trend shows price adjustments as the market reassesses value.
Long-term adjustment reflects broader market or company-specific challenges.
Veeda Clinical Research Limited Shares's share price has shown a downward trend over the past year, with a decline of 9.52%. The past 6 months have shown a -12.84% change, suggesting a period of adjustment. Recent momentum has been particularly strong with a -1.04% change in the last month.
| Company | Current Price | 1Y Change | Performance |
|---|---|---|---|
Veeda Clinical Research Limited Shares Your selection | ₹475 | -9.52% | |
Urban Tots Unlisted Shares | ₹85 | -28.00% | |
Care Health (Previously Religare Health) Insurance Company Limited Unlisted Shares | ₹186 | -18.18% | |
Polymatech Unlisted Shares | ₹66 | -32.12% | |
NSE India Limited Unlisted Shares | ₹1,750 | +91.13% |
When compared to industry peers, Veeda Clinical Research Limited Shares has outperformed comparable companies. This suggests the company is experiencing similar market challenges as its peers. Factors driving this relative performance include the company's market positioning, growth initiatives, and competitive landscape.
With our in-depth price analysis and market insights, make an informed investment decision today.
Our blog provides insightful information about unlisted shares, offering a deeper understanding of how these assets work, their potential benefits, and the risks involved. Whether you're new to unlisted shares or looking to expand your knowledge, we cover topics such as investment strategies, valuation methods, market trends, and regulatory aspects. Stay updated with expert tips and guides to navigate the unlisted share market effectively.
